✦ LIBER ✦

Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck

✍ Scribed by K.J Harrington; C Lewanski; A.D Northcote; J Whittaker; A.M Peters; R.G Vile; J.S.W Stewart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Locoregional effects of pegylated liposo

✍ Sandrine Faivre; Hassan Alsabe; Latifa Djafari; François Janot; Morbize Julieron 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Phase II study of pegylated liposomal do

✍ Leighl, Natasha B.; Goss, Glenwood D.; Lopez, Pedro; Burkes, Ronald L.; Dancey, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Phase II study of pegylated liposomal do

✍ Leighl, Natasha B.; Goss, G.D.; Lopez, P.G.; Burkes, R.L.; Dancey, J.E.; Rahim, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A Phase I Study of Pegylated Liposomal D

✍ Natasha B. Leighl; Ronald L. Burkes; Janet E. Dancey; Pedro G. Lopez; Brian P. H 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 166 KB

Phase II study of oral miltefosine in pa

✍ Verweij, J.; Planting, A.S.Th.; Stoter, G.; Gandia, D.; Armand, J.P. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Pegylated liposomal doxorubicin as third

✍ Antonio Rozzi, Daniele Santini, Margherita Salerno, Francesca Bordin, Andrea Man 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 255 KB